TipRanks
Lite Strategy (LITS)
NASDAQ:LITS
Want to see LITS full AI Analyst Report?

Lite Strategy (LITS) Price & Analysis

1,052 Followers

LITS Stock Chart & Stats

$1.00
>-$0.01(-0.49%)
At close: 4:00 PM EDT
$1.00
>-$0.01(-0.49%)

Bulls Say, Bears Say

Bulls Say
Debt-Free Balance SheetA debt-free balance sheet provides financial flexibility because the company is not burdened by mandatory interest payments or near-term debt maturities. This can help preserve strategic options and reduce refinancing pressure while management addresses the broader operating weaknesses.
Improving Cash BurnThe reduction in cash burn from the exceptionally large 2023–2024 outflows is a constructive operational trend. Although cash generation remains negative, continued improvement could extend financial flexibility and provide a better base for stabilizing the business.
Strategic Treasury And Capital ActionsThe treasury strategy, covered-call program, and authorized repurchases represent an active approach to capital and asset management. If executed effectively, these actions could support investor positioning and create additional financial tools beyond the company’s core operations.
Bears Say
Revenue Has Fallen To ZeroTwo consecutive annual periods with zero revenue indicate that the company is not currently demonstrating a repeatable operating engine. Without recurring sales, future growth and self-funded investment depend on restarting commercial activity or securing additional capital.
Large And Escalating LossesThe reversal from strong 2024 profitability to sizable losses, followed by an even larger 2026 net loss, shows that earnings are highly volatile and not yet sustainable. This weakens internal capital formation and makes long-term performance harder to assess.
Persistent Negative Cash FlowPersistent negative operating and free cash flow means the company continues consuming cash rather than funding itself through operations. Even with no debt, ongoing burn can increase dependence on external financing and constrain durable investment capacity.

Lite Strategy News

LITS FAQ

What was Lite Strategy’s price range in the past 12 months?
Lite Strategy lowest stock price was $0.69 and its highest was $2.26 in the past 12 months.
    What is Lite Strategy’s market cap?
    Lite Strategy’s market cap is $37.40M.
      When is Lite Strategy’s upcoming earnings report date?
      Lite Strategy’s upcoming earnings report date is Nov 05, 2026 which is in 7 days.
        How were Lite Strategy’s earnings last quarter?
        Lite Strategy released its earnings results on May 13, 2026. The company reported -$0.664 earnings per share for the quarter.
          Is Lite Strategy overvalued?
          According to Wall Street analysts Lite Strategy’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Lite Strategy pay dividends?
            Lite Strategy pays a Notavailable dividend of $1.75 which represents an annual dividend yield of 38.63%. See more information on Lite Strategy dividends here
              What is Lite Strategy’s EPS estimate?
              Lite Strategy’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Lite Strategy have?
              Lite Strategy has 30,407,269 shares outstanding.
                What happened to Lite Strategy’s price movement after its last earnings report?
                Lite Strategy reported an EPS of -$0.664 in its last earnings report. Following the earnings report the stock price went down -5.6%.
                  Which hedge fund is a major shareholder of Lite Strategy?
                  Currently, no hedge funds are holding shares in LITS
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Lite Strategy

                    Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.

                    Lite Strategy (LITS) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    ABVC BioPharma
                    ―
                    ―
                    Jasper Therapeutics
                    ―
                    ―
                    Prelude Therapeutics
                    ―
                    ―
                    Gain Therapeutics
                    ―
                    ―
                    Estrella Immunopharma
                    ―
                    ―

                    Ownership Overview

                    12.51%4.58%<0.01%79.21%
                    12.51% Insiders
                    <0.01% Other Institutional Investors
                    79.21% Public Companies and
                    Individual Investors
                    Popular Stocks